Join the members group    Follow Us

External Events

Big Data for Pharmacovigilance

Date: 20th – 21st June 2018
Venue: Royal College of Physicians, London
To register visit: http://www.dsru.org/courses/course-calendar/course/big-data-for-pharmacovigilance-conference/
Contact: Fiona Snelling, Education & Training Manager, EandT@dsru.org
Latest draft of the programme available here: http://www.dsru.org/wp-content/uploads/2017/06/BD_prog-4.pdf

Join us to hear how Big Data is revolutionising Pharmacovigilance from a panel of international experts from medicines regulators, industry and academia.

Pharmacovigilance is increasingly characterised by extremely large data sets from populations, individuals, disease registries, social media, pharmacogenomics and more. While big data can be messy, efforts are underway to establish strategies for ordering and structuring the data in order to put it to the best use in pharmacovigilance and ultimately public health. We will consider how best to link these large data sets and identify data clusters, the challenges and rewards of such large scale data analysis, ways to protect data security and patient confidentiality, and many other pertinent issues.

 


AHPPI Annual Meeting
Friday 22 June, 09.00 – 17.00
Church House, Westminster, London

PLease click here to see the programme and for more information.

 


Pharmacology Futures 2018 - exploring future drug development

This is a British Pharmacological Society focused meeting which will explore the technologies that will drive drug development over the next 10 to 15 years.

17 May 2018

Abstracts deadline: 16 Mar 2018

Registration deadline: 10 May 2018

Edinburgh, UK

Pharmacology Futures 2018 will explore the technologies that will drive drug development over the next 10 to 15 years, with speakers sharing their visions of the future.

During the meeting, the University of Edinburgh’s Cameron Prize for Therapeutics will be awarded to Professor Dame Sally Davies, who will speak on anti-microbial resistance.

Aims

  • To understand the role of structural genomics in generating and testing small molecule inhibitors
  • To appreciate the importance of epigenetics as a target for drug discovery
  • To recognise the role of stem cells in therapeutics, drug safety pharmacology, and drug discovery
  • To appreciate the use of biomarkers in guiding therapy
  • To understand the importance of allosteric drug binding sites for novel drug development
  • To describe trans-institute approaches to drug development for neurological diseases, using the NIMH as an example.

Download the flyer here.

Find out more and register here.

 

 

 


 

Westminster Health Forum Keynote Seminar

 

Next steps for improving cancer care in England

Morning, Tuesday, 17th July 2018 
Central London

with

  • Professor Chris Harrison, National Clinical Director, Cancer, NHS England
  • Professor Mark Caulfield, Chief Scientist, Genomics England 
  • Dr Rory Harvey, Chair, East of England Cancer Alliance and Clinical Co-Chair, National Programme of Care for Cancer
  • Dr Bernadette Lavery, Clinical Lead, Thames Valley Cancer Alliance, NHS England
  • Lucy Elliss-Brookes, Head of Cancer Analysis, National Cancer Registration and Analysis Service, Public Health England

 

Find out more here.

 


The listings and links above are provided purely for information purposes. The Faculty does do not quality-assure, or neccessarily approve or endorse any of the events listed.